InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Kirske David, Chief Financial Officer. Officer active across 2 companies, notably CTI Biopharma CORP. In total, 9 disclosures have been recorded. History available since 30 June 2021. The latest transaction was disclosed on 14 August 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
David Kirske is the Chief Financial Officer at CTI BioPharma Corp. He is responsible for the financial management of the company, including financial planning, risk management, and regulatory compliance. His expertise in finance is essential for ensuring the financial health of CTI BioPharma Corp. and supporting its strategic growth.